Abstract 009: Association of Accelerated Biological Aging in Midlife with Cardiovascular and Health Outcomes in the Framingham Offspring Study

Introduction: Biological age acceleration (BAA) constructed from multi-organ system biomarkers may better elucidate the aging process relative to chronological age (CA). We evaluated the association of BAA with long-term health outcomes among middle-aged adults. Hypothesis: We related mid-life accelerated BA to the incidence of death, CVD, and dementia. Methods: We modeled BAA using multiple biomarkers (anthropometric and biochemical indicators of vital organ systems) at the sixth examination cycle (1995-1998) for up to 2038 Framingham Offspring participants. Stratified by sex, we estimated BA using the Klemera and Doubal method (KDM) with principal components. Standardized residuals from regressing KDM-BA on CA were used to define accelerated BA (>1 SD), moderate BA ([-1 to 1 SD]), and slow BA (<-1 SD; referent). Utilizing multivariable-adjusted Cox proportional hazards and competing risk models, we related BAA to incident death, CVD, and dementia. Results: Over a median follow-up of 24 years (max 27 years), participants (mean age 57 years, 57% women) experienced 656 deaths, 454 new-onset CVD events, and 170 incident dementia outcomes. Men and women with accelerated BA had a 2.1-fold (95%CI [1.40-3.21]; p=0.0004) and a 1.7-fold higher risk for death (95%CI [1.10-2.55]; p=0.02), respectively, compared to the referent group. Women with accelerated BA had a 1.8-fold higher risk of CVD (95%CI [1.12-2.90]; p=0.02) compared to slow BA. Higher BAA was associated with a higher dementia risk (HR per SD-increase 1.25, 95%CI [1.03-1.53]; p=0.03) in women. Conclusions: Multiple biomarkers that signal the aging of biological organ systems can be combined to reflect BA. In our community-based sample, accelerated midlife BA was characterized by a higher risk of death and CVD in both sexes and with dementia risk in women. These findings underscore the importance of healthy multisystem aging over the life course.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-03-11
DOI
https://doi.org/10.1161/cir.151.suppl_1.009
Primary Topic
Cardiovascular Health and Risk Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 009: Association of Accelerated Biological Aging in Midlife with Cardiovascular and Health Outcomes in the Framingham Offspring Study

Ramachandran Srini Vasan, Stephanie Pan, Vanessa Xanthakis
Circulation
Cardiovascular Health and Risk Factors
article

Abstract 009: Association of Accelerated Biological Aging in Midlife with Cardiovascular and Health Outcomes in the Framingham Offspring Study

Ramachandran Srini Vasan, Stephanie Pan, Vanessa Xanthakis
article en

Abstract

Introduction: Biological age acceleration (BAA) constructed from multi-organ system biomarkers may better elucidate the aging process relative to chronological age (CA). We evaluated the association of BAA with long-term health outcomes among middle-aged adults. Hypothesis: We related mid-life accelerated BA to the incidence of death, CVD, and dementia. Methods: We modeled BAA using multiple biomarkers (anthropometric and biochemical indicators of vital organ systems) at the sixth examination cycle (1995-1998) for up to 2038 Framingham Offspring participants. Stratified by sex, we estimated BA using the Klemera and Doubal method (KDM) with principal components. Standardized residuals from regressing KDM-BA on CA were used to define accelerated BA (>1 SD), moderate BA ([-1 to 1 SD]), and slow BA (<-1 SD; referent). Utilizing multivariable-adjusted Cox proportional hazards and competing risk models, we related BAA to incident death, CVD, and dementia. Results: Over a median follow-up of 24 years (max 27 years), participants (mean age 57 years, 57% women) experienced 656 deaths, 454 new-onset CVD events, and 170 incident dementia outcomes. Men and women with accelerated BA had a 2.1-fold (95%CI [1.40-3.21]; p=0.0004) and a 1.7-fold higher risk for death (95%CI [1.10-2.55]; p=0.02), respectively, compared to the referent group. Women with accelerated BA had a 1.8-fold higher risk of CVD (95%CI [1.12-2.90]; p=0.02) compared to slow BA. Higher BAA was associated with a higher dementia risk (HR per SD-increase 1.25, 95%CI [1.03-1.53]; p=0.03) in women. Conclusions: Multiple biomarkers that signal the aging of biological organ systems can be combined to reflect BA. In our community-based sample, accelerated midlife BA was characterized by a higher risk of death and CVD in both sexes and with dementia risk in women. These findings underscore the importance of healthy multisystem aging over the life course.

CirculationVol. 151(Suppl_1)
Boston University (US), Boston University Academy (US)
Openalex Percentile: Top 87%
Cardiovascular Health and Risk Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.